Profile
New biomedical applications of magnetic nanoparticles for new diagnostic and therapeutic procedures are constantly developed. PTB supports these investigations by providing new measurement procedures for sensitive detection of magnetic nanoparticles in a biological environment. Furthermore, PTB contributes to the standardization of magnetic nanoparticles and supports by characterization of the measurement procedures a safe application of magnetic nanoparticles in biomedicine.
Research/Development
Measurement devices for characterisation of magnetic nanoparticlesServices
Information
Current Projects
MagNaStand (2017-2020): Toward an ISO standards for magnetic nanoparticles- quantMPI (2017-2020): Establishment of qualitative Magnetic Partice Imaging (MPI) application oriented phantoms for preclinical investigations
- PTB-Gerätezentrum (2018-2020): DFG core facility "Metrology of Ultra-Low Magnetic Fields"
- VSOP (2017-2021): Quantification of VSOP by Magnetic Particle Spectroscopy and development of sophisticated measurement methods
- DAAD Brazil (2019-2021): Quantitative imaging of magnetic nanoparticles for biomedical applications
- quantMRX (2020-2022): Quantitative magnetorelaxometry for magnetic nanoparticle monitoring assisting human cancer therapies
- magNoise (2019-2022): Establishing thermal noise magnetometry for magnetic nanoparticle characterization
- Matrix in Vision - SFB 1340 (2019-2022): Collaborative Research Cnetre 1340: In vivo Visualization of Extracellular Matrix Pathology
Past Projects
- TransMeT (2016-2019): Magnetic measurement technology for size-dependent fractionation of magnetic nanoparticles
- SSP 1681 (2014-2019): Field controlled particle matrix interactions: Synthesis multiscale modelling and application of magnetic hybrid materials: Subproject: Metrology for biomedical applications of magnetic hybrid materials
- EU FP7: Nanomag - Metrology for Magnetic Nanoparticles
- DFG: KFO 213 - Magnetische Eisenoxid-Nanopartikel für die Zelluläre und Molekulare MR-Bildgebung
- DFG: FOR 917 Nanoparticle-based targeting of gene- and cell-based therapies
- EU COST: TD 1402 - Multifunctional Nanoparticles for Magnetic Hyperthermia and Indirect Radiation Therapy (RADIOMAG)
